Amphastar Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Amphastar Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Amphastar Pharmaceuticals Inc Strategy Report
- Understand Amphastar Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View up-to-date information on Amphastar Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2022052368A1 | Application | NOVEL PROINSULIN GLARGINE AND METHOD FOR PREPARING INSULIN GLARGINE THEREFROM | A61K38/00; A61P3/10; C07K14/62; C12N15/70; C12P21/06 | March 17, 2022 |
| WO2022046976A1 | Application | AN EPINEPHRINE INJECTION FORMULATION WITH VERY LOW EPINEPHRINE CONCENTRATION AND LOW IMPURITIES DURING ITS SHELF-LIFE | A61K31/137; A61K47/02; A61K47/12; A61K47/183; A61K9/0019 | March 03, 2022 |
| WO2021226087A1 | Application | SMALL ANGLE X-RAY SCATTERING METHODS FOR CHARACTERIZING THE IRON CORE OF IRON CARBOHYDRATE COLLOID DRUG PRODUCTS | G01N33/15; G01N23/201; G01N2223/054 | November 11, 2021 |
| WO2021225974A1 | Application | EPINEPHRINE PHARMACEUTICAL FORMULATIONS FOR INTRANASAL DELIVERY | A61K31/137; A61K47/40; A61K9/0043 | November 11, 2021 |
| WO2021226098A1 | Application | NMR METHODS FOR CHARACTERIZING IRON SUCROSE | G01R33/448; G01N24/08 | November 11, 2021 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer